Le Fur Awena, Fournier Marie-Cécile, Gillaizeau Florence, Masson Damien, Giral Magali, Cariou Bertrand, Cantarovich Diego, Dantal Jacques
Institute of Transplantation, Urology and Nephrology (ITUN), Nantes University Hospital, Nantes, France.
INSERM UMR 1064, Nantes University Hospital, Nantes, France.
Transpl Int. 2016 Feb;29(2):207-15. doi: 10.1111/tri.12697. Epub 2015 Oct 29.
An association between 25 hydroxyvitamin D [25(OH)D] deficiency and type 2 diabetes was observed in the general population. Such association was not investigated in kidney transplant recipients. We prospectively evaluated 444 patients following primary kidney transplantation between 2000 and 2010. The 25(OH)D level at transplantation was classified into three grades: deficiency (< 10 ng/ml), insufficiency (≥ 10 and < 30 ng/ml), and normal range (≥ 30 ng/ml). Time to Post-Transplant Diabetes Mellitus (PTDM) was defined according to the day of first prescription of hypoglycemic treatment. The 25(OH)D level at transplantation was deficient in 88 patients, insufficient in 264 patients, and normal in 92 patients. At 1 year post-transplantation, cumulative incidence of PTDM was 13.2%. Cox multivariate analysis indicated that 25(OH)D deficiency (≤ 10 ng/ml) at the time of transplantation was an independent risk factor for PTDM within the first year post-transplantation (HR = 2.41, 95% CI 1.01-5.75, P = 0.048), whereas insufficiency tended to increase this risk, although not significantly. 25(OH)D deficiency is a new independent risk factor for PTDM within the first year after kidney transplantation. Our study suggests that 25(OH)D may be a marker of general health in kidney transplant recipients and could alert clinicians for PTDM risk.
在普通人群中观察到25羟维生素D[25(OH)D]缺乏与2型糖尿病之间存在关联。肾移植受者中尚未对此类关联进行研究。我们对2000年至2010年间接受初次肾移植的444例患者进行了前瞻性评估。将移植时的25(OH)D水平分为三个等级:缺乏(<10 ng/ml)、不足(≥10且<30 ng/ml)和正常范围(≥30 ng/ml)。移植后糖尿病(PTDM)的发病时间根据首次开具降糖治疗处方的日期确定。移植时25(OH)D水平缺乏的患者有88例,不足的患者有264例,正常的患者有92例。移植后1年,PTDM的累积发病率为13.2%。Cox多因素分析表明,移植时25(OH)D缺乏(≤10 ng/ml)是移植后第一年内发生PTDM的独立危险因素(HR = 2.41,95%CI 1.01 - 5.75,P = 0.048),而不足虽未显著增加该风险,但有增加趋势。25(OH)D缺乏是肾移植后第一年内发生PTDM的一个新的独立危险因素。我们的研究表明,25(OH)D可能是肾移植受者总体健康状况的一个标志物,并可提醒临床医生注意PTDM风险。